Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tenofovir alafenamide is an updated version of tenofovir disoproxil fumarate that is tied to better bone and kidney health.
A recent study of the direct-acting antiviral regimen included people who contracted hep C within the previous 12 months.
Researchers believe that in addition to producing antibodies against the virus, vaccines must also give rise to a cellular immune response.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related KS.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
A specific protein on the surface of immune cells taken from the tonsils indicated they were reservoir cells.
The Centers for Disease Control and Prevention estimates that about 36,400 people contracted HIV in 2018.
Results from randomized clinical trials of the antiviral drug are starting to become available.
Merck’s investigational antiretroviral is a reverse transcriptase¬ translocation inhibitor.
Researchers found women are less likely than men to accept a prescription for post-exposure prophylaxis after an assault.
The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.
Study participants treated with the monoclonal antibody had a 56% reduction in harmful cholesterol.
A majority of women interviewed in a small study expressed a preference for monthly injectable treatment over daily pills.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.